UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$498M |
| 2 |
Ametek
AME
|
+$445M |
| 3 |
Microsoft
MSFT
|
+$432M |
| 4 |
Apple
AAPL
|
+$209M |
| 5 |
Tesla
TSLA
|
+$198M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$759M |
| 2 |
Accenture
ACN
|
+$529M |
| 3 |
ConocoPhillips
COP
|
+$392M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$324M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$310M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.01% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 12.73% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Industrials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AAMI
1826
Acadian Asset Management
AAMI
$3.24B
| $936K | ﹤0.01% |
45,471
-584
| -1% | -$11K |
|
|
DICE
1827
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $935K | ﹤0.01% |
+29,957
| New | +$977K |
|
1828
Kearny Financial
KRNY
$593M
| $925K | ﹤0.01% |
91,126
+10,065
| +12% | +$101K |
|
1829
Modine Manufacturing
MOD
$10.3B
| $925K | ﹤0.01% |
46,559
-15,916
| -25% | -$295K |
|
|
GES
1830
DELISTED
Guess Inc
GES
| $923K | ﹤0.01% |
44,613
-8,675
| -16% | -$160K |
|
1831
Origin Bancorp
OBK
$1.64B
| $921K | ﹤0.01% |
25,082
+3,838
| +18% | +$152K |
|
1832
Vicor
VICR
$9.93B
| $916K | ﹤0.01% |
17,048
-228
| -1% | -$12K |
|
1833
Conduent
CNDT
$239M
| $916K | ﹤0.01% |
226,253
-2,900
| -1% | -$11.1K |
|
|
DO
1834
DELISTED
Diamond Offshore Drilling, Inc.
DO
| $915K | ﹤0.01% |
+87,993
| New | +$805K |
|
1835
Fastly Inc
FSLY
$4.31B
| $911K | ﹤0.01% |
111,250
+14,090
| +15% | +$123K |
|
1836
Great Southern Bancorp
GSBC
$873M
| $910K | ﹤0.01% |
15,303
-869
| -5% | -$52.7K |
|
1837
Healthcare Services Group
HCSG
$1.52B
| $909K | ﹤0.01% |
75,761
| – | – |
|
1838
WisdomTree
WT
$3.32B
| $906K | ﹤0.01% |
166,314
| – | – |
|
|
TVRD
1839
Tvardi Therapeutics
TVRD
$22M
| $906K | ﹤0.01% |
2,344
+14
| +0.6% | +$5.32K |
|
|
LGF.B
1840
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $906K | ﹤0.01% |
166,795
+64,996
| +64% | +$431K |
|
1841
Flywire
FLYW
$2.14B
| $905K | ﹤0.01% |
36,969
+11,579
| +46% | +$249K |
|
1842
Dine Brands
DIN
$433M
| $905K | ﹤0.01% |
14,003
-1,169
| -8% | -$81.4K |
|
|
RETA
1843
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $904K | ﹤0.01% |
23,808
+1,540
| +7% | +$53K |
|
1844
Preferred Bank
PFBC
$1.24B
| $903K | ﹤0.01% |
12,106
-2,557
| -17% | -$186K |
|
1845
Krispy Kreme
DNUT
$556M
| $902K | ﹤0.01% |
87,386
-1,935
| -2% | -$26.4K |
|
1846
James River Group Holdings
JRVR
$214M
| $901K | ﹤0.01% |
43,109
| – | – |
|
1847
National Healthcare
NHC
$3.4B
| $900K | ﹤0.01% |
15,126
+1,466
| +11% | +$88.9K |
|
1848
Altimmune
ALT
$583M
| $900K | ﹤0.01% |
+54,700
| New | +$614K |
|
1849
Alignment Healthcare
ALHC
$2.85B
| $896K | ﹤0.01% |
76,198
-13,494
| -15% | -$164K |
|
1850
Columbus McKinnon
CMCO
$559M
| $893K | ﹤0.01% |
27,505
| – | – |
|
Similar funds
UBS AM's Q4 2022 Portfolio in Review
As of Q4 2022, UBS AM held 2,824 positions worth $191B, up 7% from $178B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
UBS AM's Q4 2022 filing shows 88 new, 1,334 increased, 722 reduced and 301 closed positions. Its largest new stake was Ferguson: 543,379 shares worth $69M. The largest sale was Amgen, an estimated $759M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q4 2022 buy was Ferguson: 543,379 shares worth $69M.
- UBS AM added most to Amazon in Q4 2022, an estimated $498M increase.
- UBS AM's biggest Q4 2022 reduction was Accenture, cutting an estimated $529M.
- UBS AM fully exited Amgen in Q4 2022, selling an estimated $759M.
- UBS AM's ten largest holdings make up 19% of its $191B portfolio in Q4 2022.
- UBS AM opened 88 new positions and closed 301 in Q4 2022.
- UBS AM's portfolio value rose 7% quarter-over-quarter to $191B.
Based on UBS AM's 13F filing for Q4 2022, filed 14 Feb 2023.